Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Inventory (2016 - 2025)

Sanara MedTech's Inventory history spans 15 years, with the latest figure at $3.9 million for Q4 2025.

  • For Q4 2025, Inventory rose 43.43% year-over-year to $3.9 million; the TTM value through Dec 2025 reached $3.9 million, up 43.43%, while the annual FY2025 figure was $3.9 million, 43.43% up from the prior year.
  • Inventory reached $3.9 million in Q4 2025 per SMTI's latest filing, up from $3.4 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $5.0 million in Q3 2023 to a low of $1.2 million in Q1 2021.
  • Average Inventory over 5 years is $3.2 million, with a median of $3.4 million recorded in 2023.
  • Peak YoY movement for Inventory: soared 140.55% in 2022, then plummeted 41.64% in 2024.
  • A 5-year view of Inventory shows it stood at $2.0 million in 2021, then skyrocketed by 73.27% to $3.5 million in 2022, then soared by 32.93% to $4.7 million in 2023, then plummeted by 41.64% to $2.8 million in 2024, then skyrocketed by 43.43% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Inventory are $3.9 million (Q4 2025), $3.4 million (Q3 2025), and $3.5 million (Q2 2025).